Cite
HARVARD Citation
Cella, D. et al. (n.d.). Quality of life in patients with advanced renal cell carcinoma given nivolumab versus everolimus in CheckMate 025: a randomised, open-label, phase 3 trial. Lancet oncology. 17 (7), pp. 994-1003. [Online].